Bio-Rad discloses Sartorius AG 2022 financials: sales €4.17B, net profit €913M

BIO-RAD LABORATORIES, INC.

Sartorius AG reported 2022 sales revenue of €4,174.7M and gross profit of €2,196.5M.
EBIT of €1,064.8M and net profit of €913.1M for the year ended December 31, 2022.
Cash flow from operations €734.2M; investing activities used €1,129.9M.
Total equity at year-end €2,658.9M; current assets €2,023.2M, current liabilities €1,803.4M.
Data sourced from Sartorius's IFRS consolidated financial statements publicly disclosed on Feb 17, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.